secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cogent Biosciences, Inc. (COGT)
CIK:        0001622229
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001193125-22-174885
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cogent Biosciences raises ~$162M in underwritten public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 15,169,698 shares at $8.25 per share plus pre-funded warrants for 3,030,302 shares at $8.24.
- Underwriters exercised option to purchase an additional 2,730,000 shares on same terms.
- Gross proceeds of approximately $162 million before underwriting discounts and expenses.
- Pre-funded warrants exercisable immediately; holder cannot exceed 9.99% beneficial ownership without notice.
- Offering made under effective shelf registration statement filed May 24, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622229/000119312522174885/0001193125-22-174885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622229/000119312522174885/d256925d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-174885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer